Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data.

Journal of Pharmacokinetics and Biopharmaceutics
J G Wagner

Abstract

No abstract listed.

References

Jul 1, 1976·Journal of Pharmaceutical Sciences·A J Sedman, J G Wagner
Oct 1, 1976·Journal of Pharmacokinetics and Biopharmaceutics·J G Wagner
Dec 1, 1975·Journal of Pharmacokinetics and Biopharmaceutics·J G Wagner
Mar 1, 1976·Journal of Pharmaceutical Sciences·S Niazi
Oct 1, 1974·Clinical Pharmacology and Therapeutics·J G Wagner
Oct 1, 1974·Journal of Pharmacokinetics and Biopharmaceutics·K S AlbertJ G Wagner
Sep 18, 1965·Nature·J G WagnerO S Carpenter

❮ Previous
Next ❯

Citations

Jan 1, 1994·Journal of Clinical Pharmacology·T G WellsG L Kearns
Jan 1, 1996·Journal of Clinical Pharmacology·L P JamesG L Kearns
Jan 1, 1986·Cancer Chemotherapy and Pharmacology·D J Moore, G Powis
Jan 1, 1990·European Journal of Clinical Pharmacology·R Korpela, K T Olkkola
Feb 1, 1980·Archives of Toxicology·R A BraeckmanJ L Willems
Jan 1, 1984·Cancer Chemotherapy and Pharmacology·R G BuiceB J Gurley
Jan 1, 1981·European Journal of Clinical Pharmacology·U Gundert-RemyG H Aynilian
Jan 1, 1983·European Journal of Clinical Pharmacology·P A ReeceR Zacest
Jan 1, 1983·European Journal of Clinical Pharmacology·D J MorganR A Smallwood
Jan 1, 1984·European Journal of Clinical Pharmacology·W G Kramer, A Romagnoli
Jan 1, 1981·European Journal of Clinical Pharmacology·A SomogyiR Gugler
Jan 1, 1984·European Journal of Clinical Pharmacology·R L NationW Thompson
Jan 1, 1984·European Journal of Clinical Pharmacology·A GrahnénB Lindström
Jan 1, 1989·European Journal of Clinical Pharmacology·M FurlanutF Pasinelli
Aug 1, 1980·European Journal of Clinical Pharmacology·E J TriggsB Learoyd
Feb 1, 1980·European Journal of Clinical Pharmacology·M I RamzanC A Shanks
Jun 1, 1980·European Journal of Clinical Pharmacology·J WalkerE J Triggs
Jan 1, 1987·Cancer Chemotherapy and Pharmacology·G PowisJ N Ingle
Jan 1, 1985·European Journal of Clinical Pharmacology·S EksborgP Tahvanainen
Jan 1, 1983·European Journal of Clinical Pharmacology·M CanalA Dufour
Oct 1, 1982·European Journal of Clinical Pharmacology·L E MatherK L Austin
Jan 1, 1987·European Journal of Clinical Pharmacology·V K Piotrovskii
Jan 1, 1980·Lung·R E BrashearR E DeAtley
Jan 1, 1990·Cancer Chemotherapy and Pharmacology·W KreisR L Nelson
Nov 1, 1990·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·R S MatteoW J Chang
Jan 16, 1998·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·H TeiriäK T Olkkola
Oct 1, 1988·European Journal of Drug Metabolism and Pharmacokinetics·S Kaul, W A Ritschel
Jul 1, 1990·European Journal of Drug Metabolism and Pharmacokinetics·S Kaul, W A Ritschel
Nov 8, 2007·European Journal of Clinical Pharmacology·Teijo I SaariKlaus T Olkkola
Dec 14, 1987·The American Journal of Cardiology·D R Abernethy, S C Montamat
Dec 1, 1980·Computer Programs in Biomedicine·B R Hieb, B Shrewsbury
Apr 1, 1986·Computers and Biomedical Research, an International Journal·A Ayiomamitis
Nov 1, 1981·International Journal of Bio-medical Computing·D E Wurster, R P Shrewsbury
Jan 1, 1982·Pharmacology & Therapeutics·C L DeVane, W J Jusko
Feb 1, 1996·Journal of Clinical Anesthesia·M KirvelaK T Olkkola
May 23, 2001·Advanced Drug Delivery Reviews·M Holz, A Fahr
Mar 16, 2000·British Journal of Clinical Pharmacology·D Y MitchellJ H Powell

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.